Limits...
LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis.

Ji X, Lu H, Zhou Q, Luo K - Elife (2014)

Bottom Line: The positive transcription elongation factor b (P-TEFb) stimulates transcriptional elongation by phosphorylating Pol II and antagonizing negative elongation factors.A reservoir of P-TEFb is sequestered in the inactive 7SK snRNP where 7SK snRNA and the La-related protein LARP7 are required for the integrity of this complex.Decreased levels of LARP7 and 7SK snRNA redistribute P-TEFb to the transcriptionally active super elongation complex, resulting in P-TEFb activation and increased transcription of EMT transcription factors, including Slug, FOXC2, ZEB2, and Twist1, to promote breast cancer EMT, invasion, and metastasis.

View Article: PubMed Central - PubMed

Affiliation: Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States.

Show MeSH

Related in: MedlinePlus

qRT-PCR analysis of LARP7 mRNA levels in untransformed MCF10A and various breast cancer cell lines.PCR values were normalized to the levels of β-actin. Data are presented as the mean ± SD from three independent measurements.DOI:http://dx.doi.org/10.7554/eLife.02907.004
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4126343&req=5

fig1s1: qRT-PCR analysis of LARP7 mRNA levels in untransformed MCF10A and various breast cancer cell lines.PCR values were normalized to the levels of β-actin. Data are presented as the mean ± SD from three independent measurements.DOI:http://dx.doi.org/10.7554/eLife.02907.004

Mentions: The association between cancer progression and reduced LARP7 expression was also confirmed in a panel of breast cancer cell lines. LARP7 was expressed at relatively high levels in the untransformed mammary epithelial cell lines (MCF10A and EpH4) and noninvasive breast cancer cell lines (MCF7, BT474, T74D, and ZR75B), but was markedly reduced in all four invasive and metastatic cancer lines examined (MDA-MB-468, BT549, MDA-MB-231, and MDA-MB-435; Figure 1D). This reduction was partially due to a decrease in the LARP7 mRNA levels as shown by qRT-PCR (Figure 1—figure supplement 1). Consistent with the demonstration that LARP7 is necessary for the integrity of the 7SK snRNA (He et al., 2008), the reduced LARP7 expression in invasive breast cancer cell lines was accompanied by a decrease in 7SK snRNA (Figure 1D). Meanwhile, phosphorylation of the Pol II CTD at Ser2 positions (pSer2) strongly increased in the invasive breast cancer cell lines, indicating an increase in the P-TEFb kinase activity. Since the variations in LARP7 expression did not affect the cellular levels of CDK9 and Cyclin T1, this increase in CDK9 kinase activity is likely due to the release of P-TEFb from the inhibitory 7SK snRNP as a result of reduced LARP7 and 7SK snRNA levels. Interestingly, HEXIM1 expression did not correlate with the malignant features of the breast cancer cell lines; it was moderately reduced in three invasive cancer lines and ZR75B non-invasive cancer line, but remained high in the metastatic MDA-MB-231 cells (Figure 1D). Taken together, these data suggest a model that LARP7 is downregulated in invasive human breast cancer cells, leading to a decrease in 7SK snRNA and subsequently 7SK snRNP. This results in release of P-TEFb from the inhibitory 7SK snRNP and an increase in the phosphorylation of the P-TEFb substrates. Thus, active P-TEFb appears to play a key role in promoting breast cancer progression.


LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis.

Ji X, Lu H, Zhou Q, Luo K - Elife (2014)

qRT-PCR analysis of LARP7 mRNA levels in untransformed MCF10A and various breast cancer cell lines.PCR values were normalized to the levels of β-actin. Data are presented as the mean ± SD from three independent measurements.DOI:http://dx.doi.org/10.7554/eLife.02907.004
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4126343&req=5

fig1s1: qRT-PCR analysis of LARP7 mRNA levels in untransformed MCF10A and various breast cancer cell lines.PCR values were normalized to the levels of β-actin. Data are presented as the mean ± SD from three independent measurements.DOI:http://dx.doi.org/10.7554/eLife.02907.004
Mentions: The association between cancer progression and reduced LARP7 expression was also confirmed in a panel of breast cancer cell lines. LARP7 was expressed at relatively high levels in the untransformed mammary epithelial cell lines (MCF10A and EpH4) and noninvasive breast cancer cell lines (MCF7, BT474, T74D, and ZR75B), but was markedly reduced in all four invasive and metastatic cancer lines examined (MDA-MB-468, BT549, MDA-MB-231, and MDA-MB-435; Figure 1D). This reduction was partially due to a decrease in the LARP7 mRNA levels as shown by qRT-PCR (Figure 1—figure supplement 1). Consistent with the demonstration that LARP7 is necessary for the integrity of the 7SK snRNA (He et al., 2008), the reduced LARP7 expression in invasive breast cancer cell lines was accompanied by a decrease in 7SK snRNA (Figure 1D). Meanwhile, phosphorylation of the Pol II CTD at Ser2 positions (pSer2) strongly increased in the invasive breast cancer cell lines, indicating an increase in the P-TEFb kinase activity. Since the variations in LARP7 expression did not affect the cellular levels of CDK9 and Cyclin T1, this increase in CDK9 kinase activity is likely due to the release of P-TEFb from the inhibitory 7SK snRNP as a result of reduced LARP7 and 7SK snRNA levels. Interestingly, HEXIM1 expression did not correlate with the malignant features of the breast cancer cell lines; it was moderately reduced in three invasive cancer lines and ZR75B non-invasive cancer line, but remained high in the metastatic MDA-MB-231 cells (Figure 1D). Taken together, these data suggest a model that LARP7 is downregulated in invasive human breast cancer cells, leading to a decrease in 7SK snRNA and subsequently 7SK snRNP. This results in release of P-TEFb from the inhibitory 7SK snRNP and an increase in the phosphorylation of the P-TEFb substrates. Thus, active P-TEFb appears to play a key role in promoting breast cancer progression.

Bottom Line: The positive transcription elongation factor b (P-TEFb) stimulates transcriptional elongation by phosphorylating Pol II and antagonizing negative elongation factors.A reservoir of P-TEFb is sequestered in the inactive 7SK snRNP where 7SK snRNA and the La-related protein LARP7 are required for the integrity of this complex.Decreased levels of LARP7 and 7SK snRNA redistribute P-TEFb to the transcriptionally active super elongation complex, resulting in P-TEFb activation and increased transcription of EMT transcription factors, including Slug, FOXC2, ZEB2, and Twist1, to promote breast cancer EMT, invasion, and metastasis.

View Article: PubMed Central - PubMed

Affiliation: Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, United States.

Show MeSH
Related in: MedlinePlus